WO2004003564A3 - Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases - Google Patents
Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases Download PDFInfo
- Publication number
- WO2004003564A3 WO2004003564A3 PCT/EP2003/006748 EP0306748W WO2004003564A3 WO 2004003564 A3 WO2004003564 A3 WO 2004003564A3 EP 0306748 W EP0306748 W EP 0306748W WO 2004003564 A3 WO2004003564 A3 WO 2004003564A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- tumour
- tumours
- same
- type
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/24—Extraction; Separation; Purification by electrochemical means
- C07K1/26—Electrophoresis
- C07K1/28—Isoelectric focusing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003246592A AU2003246592A1 (en) | 2002-06-26 | 2003-06-26 | Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10229386 | 2002-06-26 | ||
DE10229386.4 | 2002-06-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004003564A2 WO2004003564A2 (en) | 2004-01-08 |
WO2004003564A3 true WO2004003564A3 (en) | 2004-12-29 |
Family
ID=29796039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/006748 WO2004003564A2 (en) | 2002-06-26 | 2003-06-26 | Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003246592A1 (en) |
WO (1) | WO2004003564A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190067944A (en) | 2004-01-22 | 2019-06-17 | 유니버시티 오브 마이애미 | Topical co-enzyme q10 formulations and methodns of use |
ES2755840T3 (en) | 2007-03-22 | 2020-04-23 | Berg Llc | Topical formulations that have increased bioavailability |
EP2271325A4 (en) | 2008-04-11 | 2011-11-09 | Cytotech Labs Llc | Methods and use of inducing apoptosis in cancer cells |
CN102124104A (en) * | 2008-08-18 | 2011-07-13 | 财团法人首尔大学校产学协力财团 | Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase |
KR20180056816A (en) | 2009-05-11 | 2018-05-29 | 베르그 엘엘씨 | Methods for treatment of disease using an epimetabolic shifter (coenzyme q10) |
SG10202010355PA (en) | 2010-03-12 | 2020-11-27 | Berg Llc | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
KR101933732B1 (en) | 2011-04-04 | 2018-12-28 | 버그 엘엘씨 | Methods of treating central nervous system tumors |
MX351781B (en) | 2011-06-17 | 2017-10-30 | Berg Llc | Inhalable pharmaceutical compositions. |
SG10201903112WA (en) | 2013-04-08 | 2019-05-30 | Berg Llc | Treatment of cancer using coenzyme q10 combination therapies |
AU2014315186B2 (en) | 2013-09-04 | 2020-02-27 | Berg Llc | Methods of treatment of cancer by continuous infusion of coenzyme Q10 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001094629A2 (en) * | 2000-06-05 | 2001-12-13 | Avalon Pharmaceuticals | Cancer gene determination and therapeutic screening using signature gene sets |
-
2003
- 2003-06-26 AU AU2003246592A patent/AU2003246592A1/en not_active Abandoned
- 2003-06-26 WO PCT/EP2003/006748 patent/WO2004003564A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001094629A2 (en) * | 2000-06-05 | 2001-12-13 | Avalon Pharmaceuticals | Cancer gene determination and therapeutic screening using signature gene sets |
Non-Patent Citations (3)
Title |
---|
KIM JINA ET AL: "Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins.", ELECTROPHORESIS, vol. 23, no. 24, December 2002 (2002-12-01), pages 4142 - 4156, XP002267151, ISSN: 0173-0835 (ISSN print) * |
POON TERENCE C W ET AL: "Proteome analysis and its impact on the discovery of serological tumor markers", CLINICA CHIMICA ACTA, vol. 313, no. 1-2, November 2001 (2001-11-01), pages 231 - 239, XP002269361, ISSN: 0009-8981 * |
SIMPSON RICHARD J ET AL: "Cancer proteomics: From signaling networks to tumor markers", TRENDS IN BIOTECHNOLOGY, vol. 19, no. 10 Supplement, 2001, pages S40 - S48, XP002269362, ISSN: 0167-7799 * |
Also Published As
Publication number | Publication date |
---|---|
AU2003246592A1 (en) | 2004-01-19 |
WO2004003564A2 (en) | 2004-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000061612A3 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
WO1999047674A3 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
WO2001000828A3 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
WO2004003564A3 (en) | Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases | |
AU7240096A (en) | Neutralizing monoclonal antibodies to respiratory syncytial virus | |
WO2001040269A3 (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
WO2000060077A3 (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
WO2000037643A3 (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
WO2003076631A3 (en) | Genetic products differentially expressed in tumors and use thereof | |
WO2002086071A3 (en) | Cancer-testis antigens | |
WO2001049716A3 (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
WO2001071357A3 (en) | Diagnosis and treatment of breast cancer | |
NZ302821A (en) | isolated truncated nucleic acid molecules which code for GAGE tumour rejection antigen precursors | |
WO2002051994A3 (en) | Polypeptides | |
MXPA01003240A (en) | Mammaglobin, a secreted mammary-specific breast cancer protein. | |
IL207012A (en) | Pharmaceutical composition comprising sgp28 and a vaccine composition for the treatment of a cancer expressing sgp28 | |
WO2005061531A1 (en) | A superantigen fusion protein used for antitumor therapy and the preparation thereof | |
WO2004013631A3 (en) | Compositions and methods for diagnosis and therapy of cancer | |
WO2005049793A3 (en) | Methods and compositions for combinatorial approaches to cancer gene therapy | |
WO2001055391A3 (en) | 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer | |
AU2806597A (en) | Human DNase II | |
CN108300725A (en) | Soluble single-chain antibody super antigen fusion and albumen and its preparation and application | |
FR2813606B1 (en) | TRUNKED PROTEIN BARD1, AND ITS DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | |
WO2003020954A3 (en) | 205p1b5 in treatment and detection of cancer | |
CN101469027A (en) | Calprotectin-blood platelet factor-4 fusion protein and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |